Milestone Pharmaceuticals Inc. - Common Shares (MIST)
CUSIP: 59935V107
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Shares
- Shares outstanding
- 124,031,000
- Total 13F shares
- 20,284,874
- Share change
- -291,381
- Total reported value
- $117,447,374
- Put/Call ratio
- 14%
- Price per share
- $5.79
- Number of holders
- 31
- Value change
- -$1,995,259
- Number of buys
- 13
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP 59935V107?
CUSIP 59935V107 identifies MIST - Milestone Pharmaceuticals Inc. - Common Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 59935V107:
Top shareholders of MIST - Milestone Pharmaceuticals Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
3.5%
|
4,315,102
|
$28,911,000 | — | 31 Dec 2020 | |
| Novo Holdings A/S |
13F
|
Company |
2%
|
2,530,585
|
$16,955,000 | — | 31 Dec 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2%
|
2,493,109
|
$16,704,000 | — | 31 Dec 2020 | |
| Boxer Capital, LLC |
13F
|
Company |
2%
|
2,477,194
|
$16,597,000 | — | 31 Dec 2020 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.9%
|
2,327,714
|
$15,596,000 | — | 31 Dec 2020 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.5%
|
1,836,545
|
$12,305,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.79%
|
977,741
|
$6,551,000 | — | 31 Dec 2020 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
851,291
|
$5,704,000 | — | 31 Dec 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.58%
|
715,786
|
$4,796,000 | — | 31 Dec 2020 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.36%
|
450,000
|
$3,015,000 | — | 31 Dec 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.3%
|
374,957
|
$2,512,000 | — | 31 Dec 2020 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.2%
|
253,610
|
$1,699,000 | — | 31 Dec 2020 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
208,332
|
$1,396,000 | — | 31 Dec 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.13%
|
164,000
|
$1,099,000 | — | 31 Dec 2020 | |
| J. Goldman & Co LP |
13F
|
Company |
0.09%
|
105,518
|
$707,000 | — | 31 Dec 2020 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.06%
|
78,295
|
$525,000 | — | 31 Dec 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.05%
|
57,411
|
$385,000 | — | 31 Dec 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.04%
|
52,300
|
$350,000 | — | 31 Dec 2020 | |
| Anson Funds Management LP |
13F
|
Company |
0.04%
|
50,113
|
$336,000 | — | 31 Dec 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
50,100
|
$336,000 | — | 31 Dec 2020 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
37,300
|
$250,000 | — | 31 Dec 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.02%
|
23,633
|
$158,000 | — | 31 Dec 2020 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
23,065
|
$155,000 | — | 31 Dec 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
22,355
|
$150,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
22,250
|
$149,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
18,945
|
$126,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.01%
|
17,016
|
$114,000 | — | 31 Dec 2020 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
14,646
|
$98,000 | — | 31 Dec 2020 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.01%
|
10,780
|
$72,226 | — | 31 Dec 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
10,144
|
$68,000 | — | 31 Dec 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,096
|
$7,000 | — | 31 Dec 2020 | |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. |
13F
|
Company |
0%
|
245
|
$2,000 | — | 31 Dec 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
156
|
$1,000 | — | 31 Dec 2020 |
Institutional Holders of Milestone Pharmaceuticals Inc. - Common Shares (MIST) as of Q1 2021
As of 31 Mar 2021,
Milestone Pharmaceuticals Inc. - Common Shares (MIST) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,284,874 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, ORBIMED ADVISORS LLC, BOXER CAPITAL, LLC, Novo Holdings A/S, RA CAPITAL MANAGEMENT, L.P., Ikarian Capital, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, and PURA VIDA INVESTMENTS, LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
33
Q1 2021 holders
31
Holder diff
-2
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.